Anne-Mari Virolainen

Anne-Mari Virolainen is the CEO of the Finnish Pharmaceutical Industry Association, and she recently commented on U.S. President Donald Trump's announcement of a 100% import tariff on patented and branded medicines, expressing concerns over the clarity and consistency of this proposal in light of the previously established 15% tariff agreement between the U.S. and the EU.